Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
9376 | 1161 | 41.0 | 87% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
8 | 4 | CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL | 1276458 |
57 | 3 | ANGIOTENSIN II//HYPERTENSION//PERIPHERAL VASCULAR DISEASES | 89232 |
85 | 2 | ANGIOTENSIN II//RENIN ANGIOTENSIN SYSTEM//ANGIOTENSIN | 27105 |
9376 | 1 | ALISKIREN//PRORENIN RECEPTOR//DIRECT RENIN INHIBITOR | 1161 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | ALISKIREN | authKW | 3764541 | 20% | 62% | 232 |
2 | PRORENIN RECEPTOR | authKW | 2790627 | 11% | 84% | 127 |
3 | DIRECT RENIN INHIBITOR | authKW | 1659097 | 7% | 78% | 81 |
4 | PRORENIN | authKW | 1353974 | 10% | 46% | 113 |
5 | RENIN | authKW | 428741 | 17% | 8% | 193 |
6 | RENIN INHIBITOR | authKW | 378619 | 5% | 24% | 60 |
7 | INTRACRINE | authKW | 349228 | 3% | 40% | 33 |
8 | DIRECT RENIN INHIBITION | authKW | 268961 | 1% | 68% | 15 |
9 | HANDLE REGION PEPTIDE | authKW | 265183 | 1% | 92% | 11 |
10 | RENIN INHIBITION | authKW | 261151 | 2% | 41% | 24 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Peripheral Vascular Diseases | 18127 | 37% | 0% | 426 |
2 | Urology & Nephrology | 1854 | 12% | 0% | 142 |
3 | Cardiac & Cardiovascular System | 1224 | 14% | 0% | 160 |
4 | Physiology | 772 | 10% | 0% | 113 |
5 | Pharmacology & Pharmacy | 638 | 16% | 0% | 184 |
6 | Endocrinology & Metabolism | 320 | 8% | 0% | 88 |
7 | Medicine, Research & Experimental | 229 | 6% | 0% | 74 |
8 | Medicine, General & Internal | 133 | 7% | 0% | 77 |
9 | Cell Biology | 52 | 6% | 0% | 65 |
10 | Hematology | 11 | 2% | 0% | 21 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | PHARMACOL VASC MED | 202278 | 2% | 38% | 20 |
2 | ENDOCRINOL PL MED SCI | 177156 | 1% | 42% | 16 |
3 | UNIT 833 | 157796 | 1% | 100% | 6 |
4 | SYNTHET WELF | 127276 | 1% | 44% | 11 |
5 | MED ENDOCRINOL HYPERTENS 2 | 99122 | 1% | 54% | 7 |
6 | VASC PHARMACOL METAB | 94673 | 1% | 60% | 6 |
7 | ANTIAGING MED ENDOCRINOL | 78898 | 0% | 100% | 3 |
8 | ENDOCRINOL ANTIAGING MED INTERNAL MED | 78898 | 0% | 100% | 3 |
9 | BEHAV SLEEP MED | 52599 | 0% | 100% | 2 |
10 | ENDOCRINOL ANTIAGING MED | 47336 | 0% | 60% | 3 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM | 93830 | 5% | 6% | 56 |
2 | HYPERTENSION | 14977 | 7% | 1% | 81 |
3 | AMERICAN JOURNAL OF HYPERTENSION | 11094 | 4% | 1% | 50 |
4 | JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION | 10673 | 1% | 3% | 16 |
5 | JOURNAL OF CLINICAL HYPERTENSION | 9533 | 2% | 2% | 20 |
6 | HYPERTENSION RESEARCH | 7141 | 2% | 1% | 26 |
7 | JOURNAL OF HYPERTENSION | 7024 | 4% | 1% | 51 |
8 | CURRENT HYPERTENSION REPORTS | 6424 | 1% | 2% | 16 |
9 | CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION | 3224 | 1% | 1% | 14 |
10 | CLINICAL AND EXPERIMENTAL NEPHROLOGY | 2514 | 1% | 1% | 10 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ALISKIREN | 3764541 | 20% | 62% | 232 | Search ALISKIREN | Search ALISKIREN |
2 | PRORENIN RECEPTOR | 2790627 | 11% | 84% | 127 | Search PRORENIN+RECEPTOR | Search PRORENIN+RECEPTOR |
3 | DIRECT RENIN INHIBITOR | 1659097 | 7% | 78% | 81 | Search DIRECT+RENIN+INHIBITOR | Search DIRECT+RENIN+INHIBITOR |
4 | PRORENIN | 1353974 | 10% | 46% | 113 | Search PRORENIN | Search PRORENIN |
5 | RENIN | 428741 | 17% | 8% | 193 | Search RENIN | Search RENIN |
6 | RENIN INHIBITOR | 378619 | 5% | 24% | 60 | Search RENIN+INHIBITOR | Search RENIN+INHIBITOR |
7 | INTRACRINE | 349228 | 3% | 40% | 33 | Search INTRACRINE | Search INTRACRINE |
8 | DIRECT RENIN INHIBITION | 268961 | 1% | 68% | 15 | Search DIRECT+RENIN+INHIBITION | Search DIRECT+RENIN+INHIBITION |
9 | HANDLE REGION PEPTIDE | 265183 | 1% | 92% | 11 | Search HANDLE+REGION+PEPTIDE | Search HANDLE+REGION+PEPTIDE |
10 | RENIN INHIBITION | 261151 | 2% | 41% | 24 | Search RENIN+INHIBITION | Search RENIN+INHIBITION |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | DANSER, AHJ , (2015) THE ROLE OF THE (PRO)RENIN RECEPTOR IN HYPERTENSIVE DISEASE.AMERICAN JOURNAL OF HYPERTENSION. VOL. 28. ISSUE 10. P. 1187 -1196 | 82 | 82% | 4 |
2 | BATENBURG, WW , DANSER, AHJ , (2012) (PRO)RENIN AND ITS RECEPTORS: PATHOPHYSIOLOGICAL IMPLICATIONS.CLINICAL SCIENCE. VOL. 123. ISSUE 3-4. P. 121-133 | 88 | 69% | 17 |
3 | KROP, M , LU, XF , DANSER, AHJ , MEIMA, ME , (2013) THE (PRO)RENIN RECEPTOR. A DECADE OF RESEARCH: WHAT HAVE WE LEARNED?.PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY. VOL. 465. ISSUE 1. P. 87 -97 | 75 | 77% | 14 |
4 | NGUYEN, G , (2011) RENIN, (PRO)RENIN AND RECEPTOR: AN UPDATE.CLINICAL SCIENCE. VOL. 120. ISSUE 5-6. P. 169 -178 | 59 | 80% | 56 |
5 | JAGADEESH, G , BALAKUMAR, P , STOCKBRIDGE, N , (2012) HOW WELL DO ALISKIREN'S PURPORTED MECHANISMS TRACK ITS EFFECTS ON CARDIOVASCULAR AND RENAL DISORDERS?.CELLULAR SIGNALLING. VOL. 24. ISSUE 8. P. 1583-1591 | 73 | 72% | 3 |
6 | RASHIKH, A , AHMAD, SJ , PILLAI, KK , NAJMI, AK , (2012) ALISKIREN AS A NOVEL THERAPEUTIC AGENT FOR HYPERTENSION AND CARDIO-RENAL DISEASES.JOURNAL OF PHARMACY AND PHARMACOLOGY. VOL. 64. ISSUE 4. P. 470-481 | 70 | 74% | 2 |
7 | DANSER, AHJ , (2010) THE INCREASE IN RENIN DURING RENIN INHIBITION: DOES IT RESULT IN HARMFUL EFFECTS BY THE (PRO)RENIN RECEPTOR?.HYPERTENSION RESEARCH. VOL. 33. ISSUE 1. P. 4-10 | 52 | 95% | 18 |
8 | BALAKUMAR, P , JAGADEESH, G , (2010) CARDIOVASCULAR AND RENAL PATHOLOGIC IMPLICATIONS OF PRORENIN, RENIN, AND THE (PRO)RENIN RECEPTOR: PROMISING YOUNG PLAYERS FROM THE OLD RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM.JOURNAL OF CARDIOVASCULAR PHARMACOLOGY. VOL. 56. ISSUE 5. P. 570 -579 | 68 | 68% | 19 |
9 | BRUNETTI, ND , DE GENNARO, L , PELLEGRINO, PL , CUCULO, A , ZICCARDI, L , GAGLIONE, A , DI BIASE, M , (2011) DIRECT RENIN INHIBITION: UPDATE ON CLINICAL INVESTIGATIONS WITH ALISKIREN.EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION. VOL. 18. ISSUE 3. P. 424 -437 | 58 | 75% | 0 |
10 | AHMED, BAM , SEDA, O , LAVOIE, JL , (2011) (PRO)RENIN RECEPTOR AS A NEW DRUG TARGET.CURRENT PHARMACEUTICAL DESIGN. VOL. 17. ISSUE 33. P. 3611-3621 | 55 | 76% | 2 |
Classes with closest relation at Level 1 |